TsuyukiRT. A new beginning, plus more of the same (Editorial). Can Pharm J (Ott)2013;146(1):5-7.
2.
TsuyukiRTCampbellN. Hypertension: Silent and/or ignored (Editorial). Can Pharm J (Ott)2013;146(2):61-64.
3.
TsuyukiRT. Pharmacists’ duty of care (Editorial). Can Pharm J (Ott)2013;146(3):125-126.
4.
TsuyukiRTKrassI. What is patient-centred care? (Editorial). Can Pharm J (Ott)2013;146(4):177-180.
5.
TsuyukiRT. On becoming a new pharmacist (Editorial). Can Pharm J (Ott)2013;146(5):241-242.
6.
TsuyukiRT. A sharpened focus on patient-centred care (Editorial). Can Pharm J (Ott)2013;146(6):305-306.
7.
HouleSKDRosenthalMMCampbellNRCDuhaneyTTsuyukiRT. Why pharmacists should care about the marketing of unhealthy foods: Increasing our role in public health policy (Editorial). Can Pharm J (Ott)2014;147(1):4-7.
8.
TsuyukiRT. The elderly and the future of pharmacy (Editorial). Can Pharm J (Ott)2014;147(2):73-74.
9.
TsuyukiRT. The “D” word (Editorial). Can Pharm J (Ott)2014;147(3):133-134.
10.
TsuyukiRTDaviesNM. Self-denigration in pharmacy: Words to banish from the pharmacy lexicon (Editorial). Can Pharm J (Ott)2014;147(4):197-199.
11.
DaviesNMTsuyukiRT. Self-denigration in pharmacy: Actions that should be curtailed (Editorial). Can Pharm J (Ott)2014;147(5):265-266.
12.
TsuyukiRT. Opportunities and Success Stories in Patient-Centred Care (Editorial). Can Pharm J (Ott)2014;147(6):325-326.
13.
TsuyukiRTMacCallumL. Delivering on our potential: Pharmacists and diabetes care (Editorial). Can Pharm J (Ott)2015;148(1):5-8.
14.
TsuyukiRT. Supporting patient-centred care (Editorial). Can Pharm J (Ott)2015;148(2):57-58.
15.
TsuyukiRT. Pharmacy students are vital to the future of the profession (Editorial). Can Pharm J (Ott)2015;148(3):109-111.
16.
TsuyukiRT. Pharmacy practice: At the tipping point? (Editorial). Can Pharm J (Ott)2015;148(4):168-170.
17.
TsuyukiRT. Reaffirming our focus on patient-centred care (Editorial). Can Pharm J (Ott)2015;148(5):225-226.
18.
ThomasJTsuyukiRT. Pharmacist 2.0 (Editorial). Can Pharm J (Ott)2015;148(6):297-298.
19.
TsuyukiRTEisenschmidP. CPJ and CPhA: Taking evidence for pharmacist care to the next level (Editorial). Can Pharm J (Ott)2016;149(1):6-7.
20.
TsuyukiRT. The primary care pharmacist (Editorial). Can Pharm J (Ott)2016;149(2):61-63.
21.
TsuyukiRTChatterleyP. Pharmacy practice publications with impact (Editorial). Can Pharm J (Ott)2016;149(3):113-115.
22.
TsuyukiRT. Pharmacists’ responses to natural disasters: Insights into the soul of pharmacists and our role in society (Editorial). Can Pharm J (Ott)2016;149(4):188-189.
23.
DolovichLTsuyukiRT. Pharmacy practice research produces findings that inform how pharmacists contribute to optimal drug therapy outcomes for Canadians (Editorial). Can Pharm J (Ott)2016;149(5):261-263.
24.
RosenthalMMAustinZTsuyukiRT. Barriers to pharmacy practice change: Is it our nature or nurture? (Editorial). Can Pharm J (Ott)2016;149(6):317-319.
25.
RosenthalMMAustinZFarrellJTsuyukiRT. Overcoming our nature and nurture (Editorial). Can Pharm J (Ott)2017;150 (1):5-7.
26.
BachynskyJATsuyukiRT. The misrepresentation of high drug costs: Who is looking out for the patient?Can Pharm J (Ott)2017;150(2):74-75.
27.
LambSTsuyukiRT. Pharmacists vs employers: A showdown over professional autonomy and patient care?Can Pharm J (Ott)2017;150(3):138-139.
28.
TsuyukiRTBergAKhanNA. The ultimate opportunity for advancing pharmacy practice (Editorial). Can Pharm J (Ott)2017;150(4):225-226.
29.
TsuyukiRTAl HamarnehYNBerminghamMDuongEOkadaHBeallJ. Predatory publishers: Implications for pharmacy practice and practitioners (Editorial). Can Pharm J (Ott)2017;150(5):274-275.
30.
ChatterleyTTsuyukiRT. Measuring the impact of CPJ on pharmacy practice (Editorial). Can Pharm J (Ott)2018;150(6):347-348.
31.
TsuyukiRTBeahmNPOkadaHAl HamarnehYN. Pharmacists as accessible primary health care providers: Review of the evidence (Editorial). Can Pharm J (Ott)2018;151(1):4-5.
32.
MacCallumLDolovichL. Follow-up in community pharmacy should be routine, not extraordinary. Can Pharm J (Ott)2018;151(2):79-8.
33.
TsuyukiRTHirshJ. Pharmacists as cognitive authorities: Why this is important in advancing patient care and our profession. Can Pharm J (Ott)2018;151(3):155-156.
34.
TsuyukiRT. FAQs (frequent asinine questions) on pharmacists’ scope of practice (Editorial). Can Pharm J (Ott)2018;151(4):212-213.
35.
TsuyukiRTHouleSKDOkadaH. Time to give up on expanded scope of practice (Editorial). Can Pharm J (Ott)2018;151(5):286-287.
36.
SanyalCHusereauDTsuyukiRT. Evidence and its impact on pharmacy practice: Don’t be “evidence-illiterate.”Can Pharm J (Ott)2018;151(6):357-358.
37.
TsuyukiRT. A leadership crisis in pharmacy (Editorial). Can Pharm J (Ott)2019;152(1):6-7.
38.
TsuyukiRTBondC. The evolution of pharmacy practice research-Part I: Time to implement the evidence. Can Pharm J (Ott)2019;152(2):71-72.
39.
TsuyukiRTNakagawaRS. Regulation and innovation in practice—Not a “drug interaction”?Can Pharm J (Ott)2019;152(3):143-144.
40.
BondCTsuyukiRT. The evolution of pharmacy practice research—Part II: Time to join the rest of the world. Can Pharm J (Ott)2019;152(4)219-220.
41.
TsuyukiRT. Pharmacists’ professional identity: A foundational problem (and solution) for our profession (Editorial). Can Pharm J (Ott)2019;152(5):277-279.
42.
KungJYLipowskiJTsuyukiRT. The impact of CPJ on practice: An update (Editorial). Can Pharm J (Ott)2019;152(6):357-361.
43.
ChanJCTsuyukiRT. Pharmacists can improve hypertension care (but you have to pay them. . .): A review of remuneration opportunities across Canada. Can Pharm J (Ott)2020;153(1):7-8.
44.
TsuyukiRTWatsonKE. Why pharmacist prescribing needs to be independent. Can Pharm J (Ott)2020;153(2):67-69.
45.
WatsonKEVan HaaftenDHoronKTsuyukiRT. The evolution of pharmacists’ roles in disasters, from logistics to assessing and prescribing. Can Pharm J (Ott)2020;153(3):129-131.
46.
FarrellBTsuyukiRT. Pharmacists step up to the challenge of COVID-19. Can Pharm J (Ott)2020;153(4):185.
47.
TsuyukiRT. Realizing our ultimate opportunity (Editorial). Can Pharm J (Ott)2020;153(5):238-239.
48.
TsuyukiRTWatsonKE. COVID-19 testing by pharmacists. Can Pharm J (Ott)2020;153(6):314-315.
49.
TsuyukiRT. Proactive practice. Can Pharm J (Ott)2021;154(1):6.
50.
WatsonKETsuyukiRT. Pharmacists must combat mis/disinformation. Can Pharm J (Ott)2021;154(2):68-69.
51.
GrindrodKWaiteNConstantinescuCWatsonKETsuyukiRT. COVID-19 vaccine hesitancy: Pharmacists must be proactive and move the middle. Can Pharm J (Ott)2021;154(3):133-135.
52.
BrownVTsuyukiRT. The pharmacist’s role in prevention of HPV-related cancers. Can Pharm J (Ott)2021;154(4):228-231.
53.
BeazelyMATsuyukiRT. The opioid crisis: Naloxone and pharmacists to the rescue. Can Pharm J (Ott)2021;154(5):289-290.
54.
TsuyukiRTAl HamarnehYNChanJCH, et al. Pharmacy, we have an image problem. . . (and here’s a solution) (Editorial). Can Pharm J (Ott)2021;154(6):353-354.
55.
GyselSTsuyukiRT. Overcoming stigma in pharmacy practice. Can Pharm J (Ott)2022;155(1):4-5.
56.
Foong-ReichertA-LGrindrodKAHouleSKDAustinZ. Quacks vs facts: Regulatory body discipline when clinicians spread COVID-19 mis/disinformation. Can Pharm J (Ott)2022;155(2):72-74.
57.
GyselSCWatsonKTsuyukiRT. Appropriate staffing for pharmacists’ full scope of practiceCan Pharm J (Ott)2022;155(3):136-138.
58.
TsuyukiRTAl HamarnehYN. Are pharmacists really “well placed”? (Editorial). Can Pharm J (Ott)2022;155(4):185-186.
59.
KellarJAustinZ. The only way round is through: Professional identity in pharmacy education and practice. Can Pharm J (Ott)2022;155(5):238-240.
60.
HouleSKDWaiteNMTsuyukiRT. Taking our best shot: Pharmacy’s vaccination success. Can Pharm J (Ott)2022;155(6):293-295.